Uterine papillary serous carcinoma following radiation therapy for carcinoma of cervix: A case report

International Journal of Gynecological Cancer

Volumn 10, Issue 3, 2000, Pages 253-256

  Park, M H ^a   Cho, S H ^a   Kang, H J ^a   Kim, S R ^a   Hwang, Y Y ^a  

^a Hanyang University   (South Korea)

Author keywords

Adenocarcinoma; p53 Protein; Papillary serous carcinoma; Radiation induced; Uterus

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PROTEIN P53;

AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; METASTASIS; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; OMENTUM; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

EID: 0033883490     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.010003253.x     Document Type: Article

References (13)

1. Uterine papillary serous carcinoma. A high malignant form of endometrial adenocarcinoma
2. Endometrial cancer following radiation therapy for cervical cancer
3. Uterine papillary serous carcinoma after radiation therapy for carcinoma of the cervix
4. Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma
5. Second pelvic malignancies following radiation therapy for cervical cancer
6. Malignancy of the uterine corpus following irradiation therapy for squamous cell carcinoma of the cervix
7. Endometrial cancers occurring 10 or more years after pelvic irradiation for carcinoma
8. Endometrial carcinoma in situ in postmenopausal women
9. Fluid detection in the uterus during and after irradiation for carcinoma of the cervix - Clinical implications
10. p53 Protein overexpression: A strong prognostic factor in uterine papillary serous carcinoma
11. Uterine papillary seorous carcinoma evolves via a p53-driven pathway
12. Uterine papillary serous carcinoma: A review
13. Uterine papillary serous carcinoma: Evaluation of long-term survival in surgically staged patients